How Chimpanzees Use Plants as Medicine in the Wild

Zoopharmacognosy is the process by which animals select and utilise biologically active substances to treat or prevent illness. While many species exhibit basic self-medication, chimpanzees provide the most compelling evidence for intentional, complex medical behaviour in the wild. Decades of field research have transformed this from anecdotal observation into a scientific discipline, demonstrating that the roots of medicine predate the human species.

Bitter Pith Chewing

One of the most striking examples of chimpanzee medicine involves the plant Vernonia amygdalina, commonly known as "bitter leaf." Most animals avoid this plant due to its toxic and intensely bitter flavour. However, researchers such as Michael Huffman have documented sick chimpanzees meticulously stripping the bark to reach the inner pith. They chew the pith and swallow the juice, carefully spitting out the fibrous material. Laboratory analysis of Vernonia samples has validated this behaviour. The plant contains high concentrations of sesquiterpene lactones and steroid glycosides, which are potent against parasites and bacteria. Remarkably, faecal analysis of these chimpanzees shows a significant reduction in intestinal parasite loads (e.g., Oesophagostomum stephanostomum) within 24 to 48 hours of ingestion.

Whole-Leaf Swallowing

While some plants work through chemistry, others work through physics. Chimpanzees have been observed selecting specific, rough-textured leaves, such as those from the Aspilia genus, and swallowing them whole without chewing. This behaviour typically occurs during the rainy season when nematode (worm) infections are at their peak. Under a microscope, these leaves are covered in tiny, hooked hairs called trichomes. Because the leaves are swallowed whole and folded, they act like a "velcro" strip as they pass through the digestive tract. The leaves physically snag and scrape adult parasites from the gut wall, expelling them alive in the faeces. This mechanical purging demonstrates a sophisticated understanding of how to manage physical ailments without the use of toxins.

Intentionality vs. Instinct

A common critique of animal intelligence is the "instinct vs. intent" debate. However, the timing of these behaviours suggests deliberate choice. Observations at Gombe Stream National Park show that medicinal plant use is episodic and seasonal. Healthy chimpanzees rarely, if ever, consume these plants. It is only when an individual displays visible symptoms, such as lethargy, diarrhoea, or loss of appetite, that they seek out these specific species. This targeted application distinguishes medicinal use from general foraging or "dietary diversity," suggesting the animals correlate specific sensations of illness with specific plant treatments.

Cultural Transmission and Learning

The use of medicine among chimpanzees is not just biological; it is cultural. Juvenile chimpanzees have been observed closely watching their mothers during the preparation of bitter pith or the ingestion of rough leaves. Furthermore, different chimpanzee communities use different "pharmacopoeias." A group in one forest might use Aspilia, while another group hundreds of miles away uses Aneilema for the same purpose. This geographic variation mirrors human traditional medicine and suggests that this knowledge is passed down through social learning and "medical traditions" rather than being hard-wired into their DNA.

Pharmacological Validation and Human Medicine

The plants selected by chimpanzees are not just placebos for the forest. When subjected to in vitro testing, extracts from these plants consistently show:

• Anthelmintic (worm-killing) properties.
• Antibacterial and antifungal activity.
• Anti-inflammatory effects.

Interestingly, many of these plants overlap with those used ethnomedicinally by local communities in Africa. This convergence suggests that humans may have historically learned about the medicinal properties of certain plants by observing primates' behaviour, a form of "animal-guided" drug discovery.

Implications for Evolutionary Biology and Conservation

The study of zoopharmacognosy reframes our understanding of the evolutionary roots of healthcare. It suggests that the cognitive foundations of medicine, recognising a symptom, identifying a remedy, and applying a treatment, are traits we share with our closest living relatives. However, this "informational wealth" is under threat. As forests are destroyed and chimpanzee populations dwindle, we are losing more than just a species; we are losing a living library of pharmacological knowledge. Medicinal plant use requires a complex, intact ecosystem. When the forest is fragmented, the "pharmacy" disappears, and knowledge of its use dies out with the elders of the chimpanzee community.

Conclusion

Chimpanzees possess the biological intelligence that enables them to navigate a world full of pathogens. By studying their use of nature's apothecary, science is uncovering the deep history of how organisms defend themselves against disease. The medical traditions of the chimpanzee remind us that we are not the only species to have discovered medicine; we are simply the latest to refine it.